Despite variable reporting, most studies report a predominance of female participants with age ranging from 31 to 60 years, with an estimated mean around 44.2 years of age
It also soothes and softens the skin
Tirzepatide (Mounjaro, Zepbound) is an FDA-approved dual GIP/GLP-1 receptor agonist for type 2 diabetes and chronic weight management
If youre ready to explore a path that helps you lose weight without exhausting you, consult with a qualified healthcare provider to discuss a personalized tirzepatide + B12 treatment plan
You may be at risk of having vitamin B deficiencies if you have Crohn's disease, autoimmune diseases, HIV, are elderly, or have a family history of the disease
these should only take a handful of minutes and should not affect the medication